Botox® Certification Levels Explained: Basic, Intermediate & Advanced Training
Compare Botox® certification levels — basic, intermediate & advanced training. Learn what each level covers, who it’s for, and how to choose the right program.
Last updated: September 2026
The number of units of Botox® needed for a forehead treatment is one of the most searched questions in aesthetic medicine, and one of the most commonly answered with a number that is close but not quite right. The FDA-approved dose for forehead lines is 20 units of Botox® Cosmetic, given as five injections of 4 units each into the frontalis muscle — the flat, fan-shaped muscle that runs across your forehead and lifts your brows.
What most articles leave out is the part that changes the answer entirely. Forehead lines are not approved as a standalone treatment. The label approves those 20 units only when they are given at the same session as 20 units for the glabellar lines between the brows, which makes the labeled forehead treatment 40 units in total. That pairing is not an upsell — it is the design of the treatment, and understanding why it exists is the difference between a smooth forehead and a heavy brow. It rests on the relationships described in our guide to the essential anatomy behind Botox® injection sites.
Below is what the current prescribing information actually says for each treatment area, how unit counts differ between products in ways that are easy to misread as pricing games, and what genuinely moves your own number up or down.
For horizontal forehead lines, the approved dose is 20 units of Botox® Cosmetic, divided into five injections of 4 units each and placed across the frontalis muscle. Your injector maps those five points to the width and strength of your own forehead rather than to a fixed grid, which is why two people can receive the same 20 units at visibly different spots.
Forehead lines are not an FDA-approved standalone treatment. The prescribing information approves the 20-unit frontalis dose only in conjunction with 20 units for the glabellar lines, for a total recommended dose of 40 units. If you are being quoted for “just the forehead,” it is worth asking how the 11 lines are being handled.
Your forehead works like a tug-of-war. The frontalis is the only muscle that pulls your brows up. The corrugator and procerus muscles sitting behind the glabellar 11 lines pull them down. In a resting face, those two teams hold each other in balance.
Relax only the frontalis and you have taken one side out of the contest. The depressor muscles keep pulling with nothing to push back, and the brows can settle lower than they started. That is the heavy, hooded feeling people describe when they say their Botox® “dropped my brow” — and it is a dosing and placement issue, not a bad product. It is also a distinct problem from true eyelid ptosis after Botox®, which involves the eyelid itself rather than the brow.
Treating both groups in the same session keeps the tug-of-war even. That clinical reality is why the FDA approved forehead lines as a concurrent treatment rather than a solo one.
A unit is a measure of biological activity, not of volume. It is defined by the manufacturer’s own laboratory potency test, which means a unit is a unit only within a single product. This sounds like a technicality until you are comparing two clinic quotes, at which point it becomes the single most useful thing to understand — more on that below.
Botox® Cosmetic is supplied as a vacuum-dried powder in 50-unit and 100-unit single-dose vials, which the provider reconstitutes with sterile saline before injecting. That is why your treatment is described in units rather than millilitres.
Botox® Cosmetic carries three approved cosmetic indications. Here is exactly what the label specifies for each:
| Treatment area | Total units | Injection sites | Units per site |
|---|---|---|---|
| Glabellar lines (the 11 lines) | 20 units | 5 — two in each corrugator, one in the procerus | 4 units |
| Forehead lines (frontalis) | 20 units approved only with glabellar treatment | 5 across the frontalis | 4 units |
| Lateral canthal lines (crow’s feet) | 24 units | 6 — three per side | 4 units |
| All three areas at one session | 64 units | 16 injection points | 4 units |
If this is your first treatment, a conservative starting dose is standard practice and a good sign that your injector is being careful. Starting lower lets both of you see how your muscles respond before committing to a full dose, and a top-up two weeks later is straightforward. Removing product that has already been placed is not possible — you simply wait it out.
Your injector should assess you in motion rather than at rest: how strongly you raise your brows, whether your lines are still visible when your face is relaxed, and where your brow sits naturally. Static lines that remain when your face is still are etched into the skin and respond only partially to a neurotoxin, no matter how many units are used.
Once your pattern is established, most people settle into a treatment roughly every three to four months.
The approved dose for the vertical lines between the brows is 20 units — 4 units into each of five sites, with two injections in each corrugator muscle and one in the procerus. Figures such as 25 units circulate widely online but are not labeled doses.
The glabellar complex is often the strongest muscle group in the upper face, particularly in men, and it is the area where a provider is most likely to work at the top of the labeled range at follow-up visits.
The approved dose for lateral canthal lines is 24 units in total: 4 units into each of three sites per side, or 12 units per eye. The 20-to-30-unit range you will find quoted in most consumer articles brackets the real figure without landing on it.
Crow’s feet sit over the orbicularis oculi, a thin ring-shaped muscle right at the edge of the eye socket, which is why placement matters more here than dose. Injecting too close to the orbit is what produces complications in this area.
This is the most important thing to understand before comparing clinic quotes. Every botulinum toxin product measures its units against its own potency assay, and every label carries an explicit statement that its units cannot be compared to or converted into the units of any other product.
In practical terms: if one clinic quotes 20 units and another quotes 50 for the same treatment area, that is not a markup. They are using different measuring scales, in the same way that a distance in kilometers has a larger number than the same distance in miles.
| Product | Active ingredient | Approved glabellar dose | Units per site (5 sites) |
|---|---|---|---|
| Botox® Cosmetic | onabotulinumtoxinA | 20 units | 4 units |
| Dysport® | abobotulinumtoxinA | 50 units | 10 units |
| Xeomin® | incobotulinumtoxinA | 20 units | 4 units |
| Jeuveau® | prabotulinumtoxinA-xvfs | 20 units | 4 units |
| Daxxify® | daxibotulinumtoxinA-lanm | 40 units | 8 units |
| Letybo® | letibotulinumtoxinA-wlbg | 20 units | 4 units |
One further distinction matters for this page in particular: Botox® Cosmetic is the only one of these products FDA-approved for forehead lines. The others carry approval for the glabellar lines alone. Treating the forehead with any of them is an off-label use — common and widely practiced, but worth knowing you are being offered.
The labeled framework is the safest place to anchor: 20 units for the frontalis, given with 20 units for the glabellar lines, and up to 64 units if all three approved upper-face areas are treated at once. Providers do sometimes work outside those figures for individual anatomy, but that is a clinical judgment rather than a menu option.
The more useful point is that more units is not a better result on the forehead. Over-treating the frontalis is precisely what produces the heavy, expressionless brow people are trying to avoid. If your forehead lines are not fully softening at the labeled dose, the answer is usually placement, muscle balance, or the fact that the lines are static rather than dynamic — not simply more product.
Micro-dosing — often marketed as “baby Botox®” or preventative Botox® — means deliberately using a fraction of the labeled dose, spread over more injection points, to soften movement without removing it. It is popular with younger patients and with anyone who needs full expression for their work.
Two honest caveats. Micro-dosing is an off-label dosing approach rather than an approved protocol, and a lighter dose generally means a shorter duration, so treatments come round more often. It is a legitimate technique in experienced hands, but it is a different trade-off, not a discount.
Botox® Cosmetic has a long safety record in the hands of a qualified injector, and the most common reactions are localized and temporary. It is worth knowing the real figures rather than the generic lists that circulate online, because the reactions that actually occur most often are specific to the area being treated.
Most Common Reported Reactions, by Treatment Area
Rates as reported in the Botox® Cosmetic prescribing information for each indication. Bars are scaled to a 10% maximum for readability.
Eyelid ptosis — a temporarily drooping upper lid — is the reaction most people are actually worried about, and at 3% it is the most frequently reported one for glabellar treatment. It resolves on its own as the effect wears off, and it is strongly influenced by injection technique.
Serious reactions are rare but real. Seek medical attention promptly for any swallowing, speech, or breathing difficulty, generalized muscle weakness, or vision changes following treatment.
Botox® Cosmetic is FDA-approved for exactly three cosmetic areas: glabellar lines, forehead lines, and lateral canthal lines. Everything else you will see on a clinic menu is an off-label use — legal, common, and often effective, but not backed by an approved dosing protocol, which makes your injector’s training the main safeguard.
| Area | What it treats | Status |
|---|---|---|
| Glabellar lines | Vertical 11 lines between the brows | FDA-approved |
| Forehead lines | Horizontal lines across the frontalis | FDA-approved (with glabellar) |
| Lateral canthal lines | Crow’s feet at the outer corners of the eyes | FDA-approved |
| Bunny lines | Wrinkles along the sides of the nose from the nasalis muscle | Off-label |
| Perioral lines | Fine vertical lines above the upper lip | Off-label |
| Marionette lines / chin | Lines from the mouth corners downward; chin dimpling | Off-label |
| Masseter | Jaw slimming and clenching | Off-label |
Bunny lines are frequently mislabeled in consumer articles as the lines above the lip. They are two different areas with different muscles and different doses: bunny lines sit along the sides of the nose, while the lines above the lip are perioral. Getting that distinction right matters when areas are combined, which is the subject of our guide to full-face Botox® strategy and facial harmony.
Because units are the pricing currency for this treatment, they are also where the market gets distorted. The FDA has issued repeated warnings about counterfeit product sold through unlicensed online channels, and the CDC has investigated harmful reactions in people who received injections from unlicensed individuals or in non-clinical settings.
A genuine vial has a real wholesale cost, so a price far below the local market is telling you something about the product, the setting, or the injector — and usually more than one of the three. Before booking, it is fair to ask which product is being used, that it be opened and reconstituted in front of you, and who is performing and supervising the injection. State rules vary considerably on that last point, as our overview of whether nurse practitioners can inject Botox® sets out.
The labeled onset is one to two days after injection, with the effect building in intensity through the first week. Most people book their follow-up assessment at around two weeks, when the result is fully settled and any refinement can be judged accurately.
The duration of effect is approximately three to four months. Movement returns gradually rather than all at once, and repeat treatment restores the result. There is no clinical requirement to start at any particular age, and no penalty for stopping — muscles simply return to their previous behavior.
For clinicians, the figures above are a floor, not a protocol. The labeled 20 units for the frontalis assumes concurrent glabellar treatment precisely because isolated frontalis chemodenervation removes the only brow elevator and leaves the depressor complex unopposed; brow ptosis in the forehead-line trials was reported at 2%, and technique accounts for much of the variance around that number.
Practical considerations that separate a competent result from a good one: assess brow position and frontalis recruitment dynamically before any product is drawn up; keep injection points at least 2 cm above the orbital rim and avoid the lateral frontalis in patients who compensate with brow elevation; document baseline photography at rest and in animation; and treat static rhytides as a resurfacing or filler conversation rather than a dosing one. Patients with low-set brows, significant dermatochalasis, or a short frontalis are the ones most likely to be dissatisfied by a textbook dose.
Unit conversion between products deserves particular care in a multi-toxin practice, since no validated conversion ratio exists and every label states so explicitly. Providers building or expanding an injectable service will find the full scope-of-practice picture in our guide to RN Botox® injection training, state scope, and supervision.
Get self-paced access to a real IAPAM Botox® module — watch step-by-step injection technique, follow along with our physician instructors, and claim 1 AMA PRA Category 1 CME when you finish.
What’s Inside Your Free Module
Eligibility: MD/DO, NP, APRN/CRNA, PA, DMD/DDS, RN
Enter your details and we’ll email your access link.
The FDA-approved dose for forehead lines is 20 units of Botox® Cosmetic, given as five injections of 4 units each into the frontalis muscle. The label approves this dose only when it is given at the same session as 20 units for the glabellar lines, so the labeled forehead treatment is 40 units in total. Your injector may adjust within that framework based on your muscle strength and line severity.
The frontalis is the only muscle that lifts your brows, and the corrugator and procerus muscles behind the 11 lines are the muscles that pull them down. If the frontalis is relaxed on its own, the depressor muscles have nothing to work against and the brows can feel heavy. Treating both groups together keeps that balance, which is why the FDA approved forehead lines only as a concurrent treatment with the glabellar lines.
The FDA-approved dose for glabellar lines, the vertical 11 lines between the brows, is 20 units of Botox® Cosmetic: 4 units into each of five sites, two in each corrugator muscle and one in the procerus. Figures such as 25 units are not labeled doses.
The FDA-approved dose for lateral canthal lines, or crow’s feet, is 24 units of Botox® Cosmetic in total: 4 units into each of three sites per side, 12 units per eye. Ranges such as 20 to 30 units are common online but the labeled dose is 24.
No. Units are specific to each product’s own potency assay and cannot be converted between products. Every neurotoxin label carries an explicit statement to that effect. For the glabellar lines the approved doses are 20 units of Botox® Cosmetic, 20 units of Xeomin®, 20 units of Jeuveau®, 20 units of Letybo®, 40 units of Daxxify® and 50 units of Dysport®. A higher unit number does not mean a stronger treatment or a worse deal.
The labeled onset is one to two days after injection, with the effect increasing in intensity through the first week. The duration of effect is approximately three to four months, after which movement gradually returns and a repeat treatment is needed to maintain the result.
Unit counts are the easiest part of this treatment to memorize and the hardest part to apply well. The labeled doses tell you where to start; reading a patient’s brow position, muscle recruitment, and expectations is what determines whether 20 units produces a rested face or a heavy one — and that judgment is built at the injection table, not from a chart.
The IAPAM’s four-day symposium in Scottsdale, Arizona delivers hands-on Botox® training on live models in a working clinic, taught by board-certified physician instructors, with 33.5 AMA PRA Category 1 CMEs and the business foundations to put the clinical skills to work.
Explore Botox® Training Options
Disclaimer: This guide is for informational and educational purposes only and does not constitute medical advice. Treatment plans, injection techniques, and dosing must be tailored to each patient by a qualified, licensed provider. Always follow product labeling, your scope of practice, and your state medical and nursing board regulations.
Compare Botox® certification levels — basic, intermediate & advanced training. Learn what each level covers, who it’s for, and how to choose the right program.
Learn Botox® continuing education requirements for physicians, NPs, PAs, and dentists — how many CME/CE credits you need and how to choose quality training.
Master full face Botox injection strategy: unit planning, sequencing, and how to balance the upper, mid, and lower face for natural, harmonious results.
Hands-On Aesthetic Medicine Training
Gain the confidence to start seeing patients right away.
Attend IAPAM’s comprehensive AMA PRA Category 1 CME BOTOX® training weekend and learn the clinical and business foundations for aesthetic practice growth.
Terms and conditions apply. Offer expires October 31.